Models of HIV-1 disease: A review of current status

Drug Discovery Today: Disease Models

Volumn 3, Issue 1, 2006, Pages 113-119

  Stoddart, Cheryl A ^a   Reyes, Richard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CAT; COMPUTER MODEL; CULTURE MEDIUM; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LICENCE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIMATE; RAT; REVIEW; TREATMENT FAILURE; VIRION; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 33645878586     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.03.016     Document Type: Review

References (40)

1. Steinman R.M., et al. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276 (2003) 1-30
2. Beignon A.S., et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115 (2005) 3265-3275
3. Collman R.G., et al. HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. J. Leukoc. Biol. 74 (2003) 631-634
4. Coakley E., et al. Assessing chemokine co-receptor usage in HIV. Curr. Opin. Infect. Dis. 18 (2005) 9-15
5. Glushakova S., et al. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat. Med. 1 (1995) 1320-1322
6. Bonyhadi M.L., et al. Development of a human thymic organ culture model for the study of HIV pathogenesis. AIDS Res. Hum. Retroviruses 11 (1995) 1073-1080
7. Stoddart C.A., et al. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat. Med. 7 (2001) 712-718
8. Penn M.L., et al. Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues. AIDS Res. Hum. Retroviruses 17 (2001) 517-523
9. Namikawa R., et al. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172 (1990) 1055-1063
10. Rabin L., et al. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob. Agents Chemother. 40 (1996) 755-762
11. Kollmann T.R., et al. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J. Exp. Med. 179 (1994) 513-522
12. Mosier D.E., et al. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251 (1991) 791-794
13. Persidsky Y., and Gendelman H.E. Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigms. J. Neurovirol. 8 Suppl. 2 (2002) 49-52
14. Pincus S.H., et al. A modified SCID mouse model of HIV infection with utility for testing anti-HIV therapies. AIDS Res. Hum. Retroviruses 19 (2003) 901-908
15. Taggart B.R., et al. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model. Antiviral Res. 63 (2004) 1-6
16. Di Fabio S., et al. Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides. AIDS 15 (2001) 2231-2238
17. Mariani R., et al. A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74 (2000) 3859-3870
18. Leonard J.M., et al. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242 (1988) 1665-1670
19. Sun J., et al. CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate. J. Virol. 80 (2006) 1850-1862
20. Keppler O.T., et al. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med. 195 (2002) 719-736
21. Mattapallil J.J., et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 (2005) 1093-1097
22. Li Q., et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 (2005) 1148-1152
23. Veazey R.S., et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 (1998) 427-431
24. North T.W., et al. Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. J. Virol. 79 (2005) 7349-7354
25. Van Rompay K.K. Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments. AIDS Rev. 7 (2005) 67-83
26. Veazey R.S., et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438 (2005) 99-102
27. Lederman M.M., et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306 (2004) 485-487
28. Shiver J.W., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 (2002) 331-335
29. Ferrantelli F., et al. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J. Infect. Dis. 189 (2004) 2167-2173
30. Harouse J.M., et al. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284 (1999) 816-819
31. Reyes R.A., et al. Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus. J. Virol. 78 (2004) 2121-2130
32. Harouse J.M., et al. CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques. Proc. Natl. Acad. Sci. U S A 100 (2003) 10977-10982
33. Silvestri G., et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18 (2003) 441-452
34. Burkhard M.J., and Dean G.A. Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr. HIV Res. 1 (2003) 15-29
35. In: Friedman H. (Ed). In vivo Models of HIV Disease and Control (2006), Springer
36. Blower S.M., et al. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 287 (2000) 650-654
37. Perelson A.S., et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271 (1996) 1582-1586
38. Korber B., et al. Timing the ancestor of the HIV-1 pandemic strains. Science 288 (2000) 1789-1796
39. McCune J.M. Animal models of HIV-1 disease. Science 278 (1997) 2141-2142
40. Picker L.J., and Watkins D.I. HIV pathogenesis: the first cut is the deepest. Nat. Immunol. 6 (2005) 430-432